Newly defined sleep profiles are associated with different biopsychosocial featuresFindings may be a step toward a more personalized understanding of sleep complaints. Aha! Why the brain remembers insightsMRI study reveals details of the impact of ‘eureka’ moments. Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease Lecanemab, marketed as Leqembi, targets amyloid buildup in the brain. Getting closer to being able to test for post-COVID brain fog An increased density of a particular brain receptor found in long-COVID patients. Neurological conditions are the leading cause of sickness and disability worldwide: WHO report calls for action More than 3 billion people have a neurological disorder. WHO wants governments to do more to tackle these conditions. GLP-1 inhibitors may protect against brain degeneration Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality. Why some autistic people don’t speak Around a third of autistic people—children and adults alike—are unable to share what they want using speech. First Canadian guidelines for clinical care of spinal bulbar muscular atrophy Also known as Kennedy’s disease, the neuromuscular disorder has the highest global prevalence in Saskatchewan. Dementia medications: knowing when to stop The guidelines recommend beginning discussions about deprescribing after a patient has been on medication for 12 months. New FAQ resource for pharmacists on acetaminophen use in pregnancy The Canadian Pharmacists Association has put together a resource preempting questions expectant mothers are likely to have about the common pain reliever. First Previous 1 2 3 4 5 Next Last
